Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 324 (1-2) , 1-11
- https://doi.org/10.1016/s0009-8981(02)00187-0
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCGPrenatal Diagnosis, 2000
- Utilization of Amniocentesis by Women Screening Positive for Down Syndrome on the Second-Trimester Triple TestPublic Health Genomics, 2000
- Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?Prenatal Diagnosis, 2000
- Appropriate biochemical parameters in first-trimester screening for Down syndromePrenatal Diagnosis, 1999
- Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterNew England Journal of Medicine, 1998
- Antenatal Screening for Down's SyndromeJournal of Medical Screening, 1997
- Maternal serum screening for Down syndrome in the United States: A 1995 surveyAmerican Journal of Obstetrics and Gynecology, 1997
- The Safety and Efficacy of Chorionic Villus Sampling for Early Prenatal Diagnosis of Cytogenetic AbnormalitiesNew England Journal of Medicine, 1989
- Clinical Applications of Pregnancy Protein Estimations with Particular Reference to Pregnancy-Associated Plasma Protein A (PAPP-A)Obstetrical & Gynecological Survey, 1988
- Pregnancy-associated plasma protein A in the prediction of early pregnancy failureAmerican Journal of Obstetrics and Gynecology, 1983